Pelliciari, Davy Henrique Sousa, Caio Ricco Alves Reis, and Carlos Alberto Bordini. 2024. “Should Anti-CGRP Monoclonal Antibodies Always Be the Drug of First Choice for Migraine Prophylaxis in Brazil? – a Pharmacoeconomic Study”. Headache Medicine 15 (Supplement):98. https://headachemedicine.com.br/index.php/hm/article/view/1230.